Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
MELLIN GW, 1962, NEW ENGL J MED, V267, P1184 MELLIN GW, 1962, NEW ENGL J MED, V267, P1238 LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555 LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232 KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426 SHESKIN J, 1965, LEPROSY REV, V36, P183 WIEDEMANN HR, 1961, MED WELT, V37, P1863 BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095 |
Nodes: 2685,
Authors: 6203,
Journals: 662,
Outer References: 16023,
Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by journal name.
Page 9: 1 2 3 4 5 6 7 8 9
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
---|---|---|---|---|---|
2401 | 7 | 25 | 174 1962 PRESSE MEDICALE 70(44):2053-& FARIZON F; MASBERNARD A EMBRYOPATHIE A LA THALIDOMIDE | 3 | 4 |
2402 | 1 | 5 | 255 1963 PRESSE MEDICALE 71(45):2151-& PIZON P A PROPOS DES MALFORMATIONS PROVOQUEES PAR LA THALIDOMIDE | 0 | 0 |
2403 | 1 | 2 | 830 1983 PRESSE MEDICALE 12(15):963-963 BARRIERE H SARCOIDOSIS OF THE SKIN - TREATMENT WITH THALIDOMIDE | 12 | 16 |
2404 | 2 | 4 | 831 1983 PRESSE MEDICALE 12(47):3007-3007 PRIGENT F; OUAZZANI W SARCOIDOSIS OF THE SKIN - TREATMENT WITH THALIDOMIDE | 4 | 4 |
2405 | 0 | 2 | 1027 1990 PRESSE MEDICALE 19(15):722-722 LIVROZET JM; FRANC C; GRANIER JL; BRETON P; TOURAINE JL THALIDOMIDE TREATMENT OF CHOICE OF APHTHAE IN HIV-INFECTION - REPLY | 0 | 0 |
2406 | 1 | 4 | 1028 1990 PRESSE MEDICALE 19(15):722-722 SAMSON J; KUFFER R; RADEFF B THALIDOMIDE TREATMENT OF CHOICE OF APHTHAE IN HIV-INFECTION | 2 | 2 |
2407 | 1 | 3 | 1110 1993 PRESSE MEDICALE 22(1):37-37 PEDAILLES S; TROUSSARD X; LAUNAY V; BAZIN A; SENTIAS C; SURBLED M SCLERODERMATOUS SKIN REACTION IN GRAFT-VERSUS-HOST DISEASE TREATED WITH THALIDOMIDE | 2 | 2 |
2408 | 2 | 3 | 1111 1993 PRESSE MEDICALE 22(26):1233-1233 BODOKH I; LACOUR JP; RAINERO C; CASTANET J; MICHIELS JF; ORTONNE JP EFFECTIVENESS OF THALIDOMIDE AGAINST ESOPHAGEAL ULCERATION IN HIV-INFECTION | 3 | 3 |
2409 | 2 | 3 | 1220 1995 PRESSE MEDICALE 24(1):40-40 COUDERC LJ; MATHEZ D; LEIBOWITCH J; AUTRAN B; CAUBARRERE I PROLONGED THALIDOMIDE TREATMENT IN AN HIV-INFECTED PATIENT | 0 | 1 |
2410 | 3 | 3 | 1998 2001 PRESSE MEDICALE 30(20):1008-1009 Pouaha J; Martin S; Trechot P; Truchetet F; Barbaud A; Schmutz JL Thalidomide and thrombosis: three cases | 5 | 5 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2411 | 8 | 11 | 2551 2003 PRESSE MEDICALE 32(40):1894-1898 Brocvielle H; Muret P; Plenat E; Kantelip JP; Humbert P Management of a patient receiving thalidomide | 0 | 0 |
2412 | 1 | 24 | 1112 1993 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90(13):5974-5978 MAKONKAWKEYOON S; LIMSONPOBRE RNR; MOREIRA AL; SCHAUF V; KAPLAN G THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 | 105 | 184 |
2413 | 14 | 29 | 1160 1994 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91(9):4082-4085 DAMATO RJ; LOUGHNAN MS; FLYNN E; FOLKMAN J THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS | 326 | 719 |
2414 | 13 | 32 | 1293 1996 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 93(15):7552-7556 Turk BE; Jiang H; Liu JO Binding of thalidomide to alpha(1)-acid glyeoprotein may be involved in its inhibition of tumor necrosis factor alpha production | 39 | 47 |
2415 | 10 | 24 | 762 1981 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 78(4):2545-2548 GORDON GB; SPIELBERG SP; BLAKE DA; BALASUBRAMANIAN V THALIDOMIDE TERATOGENESIS - EVIDENCE FOR A TOXIC ARENE OXIDE METABOLITE | 48 | 89 |
2416 | 2 | 6 | 352 1965 PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON 58(7):491-& SMITHELL.RW THALIDOMIDE LEGACY | 0 | 12 |
2417 | 1 | 2 | 353 1965 PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON 58(7):493-& LIVINGST.G CONGENITAL EAR ABNORMALITIES DUE TO THALIDOMIDE | 0 | 30 |
2418 | 1 | 7 | 354 1965 PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON 58(7):497-& WOOLLAM DHM PRINCIPLES OF TERATOGENESIS - MODE OF ACTION OF THALIDOMIDE | 6 | 12 |
2419 | 4 | 12 | 655 1977 PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON 70(4):225-227 NEWMAN CGH CLINICAL OBSERVATIONS ON THALIDOMIDE SYNDROME | 0 | 13 |
2420 | 0 | 3 | 10 1960 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 103(3):580-581 HARRIS SC; ALLGOOD JP ANALGESIA ENHANCING EFFECT OF THALIDOMIDE | 1 | 4 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2421 | 1 | 6 | 175 1962 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 109(3):511-& MACKENZIE RD; MCGRATH WR ABSORPTION OF THALIDOMIDE IN RAT | 25 | 29 |
2422 | 5 | 11 | 256 1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 112(4):1022-& POLKWILL.A; REUYLLUT.H; BLATTNER RJ ABNORMALITIES IN CHICK EMBRYOS FOLLOWING THALIDOMIDE AND OTHER INSOLUBLE COMPOUNDS IN AMNIOTIC CAVITY | 0 | 0 |
2423 | 11 | 15 | 257 1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 113(3):619-& SHORB MS; POLLARD W; VASAITIS V; LUND PG; SMITH C EFFECT OF THALIDOMIDE TREATMENT OF HENS ON EMBRYONIC DEVELOPMENT AND FERTILITY | 3 | 7 |
2424 | 4 | 17 | 258 1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 114(2):326-& FRANK O; HUTNER SH; SOBOTKA H; BAKER H TOXICITY TO PROTOZOA OF THALIDOMIDE BREAKDOWN PRODUCTS - COUNTERACTION BY NICOTINIC ACID AND GLUTAMINE | 8 | 12 |
2425 | 1 | 8 | 300 1964 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 116(2):512-& KORANSKY W; ULLBERG S AUTORADIOGRAPHIC INVESTIGATIONS OF 14C-LABELLED THALIDOMIDE + GLUTETHIMIDE IN PREGNANT MICE | 5 | 15 |
2426 | 1 | 10 | 558 1972 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 140(1):167-& GELATO M; QUADRI SK; MEITES J INHIBITION OF PROLACTIN RELEASE BY A THALIDOMIDE-RELATED COMPOUND (CG 603) | 0 | 3 |
2427 | 0 | 76 | 559 1972 PSYCHOLOGISCHE PRAXIS (46):1-& KIRCHHOF.H PRENATALLY HANDICAPPED CHILDREN IN SCHOOL COMMUNITIES - MODEL IN HAMBURG FOR SCHOOLING OF THALIDOMIDE CHILDREN | 0 | 0 |
2428 | 1 | 4 | 488 1969 PSYCHONOMIC SCIENCE 15(1):55-& LINDBURG DG BEHAVIOR OF INFANT RHESUS MONKEYS WITH THALIDOMIDE-INDUCED MALFORMATIONS - A PILOT STUDY | 0 | 6 |
2429 | 4 | 17 | 905 1985 PSYCHOPHARMACOLOGY 85(1):47-50 KAITIN KI EFFECTS OF THALIDOMIDE AND PENTOBARBITAL ON NEURONAL-ACTIVITY IN THE PREOPTIC AREA DURING SLEEP AND WAKEFULNESS IN THE CAT | 3 | 6 |
2430 | 1 | 14 | 176 1962 PUBLIC HEALTH REPORTS 77(11):946-946 [Anon] THALIDOMIDE | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2431 | 16 | 59 | 1783 2000 QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS 93(5):305-311 Davey PP; Ashrafian H New therapies for heart failure: is thalidomide the answer? | 6 | 9 |
2432 | 26 | 48 | 1999 2001 QUIMICA NOVA 24(5):683-688 Lima LM; Fraga CAM; Barreiro EJ The rebirth of a drug: Thalidomide | 0 | 1 |
2433 | 5 | 25 | 2284 2002 RADIOLOGE 42(3):222-230 Scherer A; Strupp C; Wittsack HJ; Engelbrecht V; Willers R; Germing U; Gattermann N; Haas R; Modder U Dynamic contrast-enhanced MRI for the evaluation of bone marrow microcirculation in hematologic malignancies before and during thalidomide therapy | 0 | 0 |
2434 | 0 | 0 | 2000 2001 RADIOLOGY 221:387-387 Faria SC; Charnsangavej C; Sawaf Y; Hess KR; Tamm EP; Lee T CT quantification of antiangiogenic effects of thalidomide | 0 | 0 |
2435 | 0 | 32 | 763 1981 REHABILITATION 20(3):128-132 WEINWURMKRAUSE EM PARTNERSHIP AND SEXUALITY OF THALIDOMIDE-AFFECTED YOUNG-PEOPLE | 0 | 0 |
2436 | 0 | 18 | 764 1981 REHABILITATION 20(4):159-164 WEINWURMKRAUSE EM THE SITUATION OF THALIDOMIDE-AFFECTED YOUNG-PEOPLE IN CHOOSING AN OCCUPATION | 0 | 2 |
2437 | 0 | 1 | 731 1980 REHABILITATION LITERATURE 41(1-2):36-38 [Anon] SUFFER THE CHILDREN - STORY OF THALIDOMIDE | 0 | 0 |
2438 | 0 | 0 | 1294 1996 REPRODUCTIVE TOXICOLOGY 10(1):1-2 Robert E Thalidomide and isotretinoin - Why treat them differently? | 2 | 6 |
2439 | 14 | 40 | 1598 1999 REPRODUCTIVE TOXICOLOGY 13(6):547-554 Hansen JM; Carney EW; Harris C Differential alteration by thalidomide of the glutathione content of rat vs. rabbit conceptuses in vitro | 6 | 10 |
2440 | 5 | 32 | 1384 1997 RESPIRATORY MEDICINE 91(1):31-39 Tavares JL; Wangoo A; Dilworth P; Marshall B; Kotecha S; Shaw RJ Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages | 23 | 38 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2441 | 0 | 0 | 1161 1994 REVISTA BRASILEIRA DE GENETICA 17(4):449-464 SALDANHA PH THE THALIDOMIDE-TRAGEDY AND THE BIRTH OF EXPERIMENTAL TERATOLOGY | 0 | 0 |
2442 | 2 | 7 | 1295 1996 REVISTA CLINICA ESPANOLA 196(4):270-271 Tercedor J; delaTorre ML; Rodenas JM Disseminated xanthoma with insipid diabetes: Therapeutic failure of thalidomide | 0 | 0 |
2443 | 3 | 15 | 930 1986 REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO 28(1):12-14 ARRUDA WO; HACBARTH E; DOI E; SANTAMARIA JR; BARBOSA J; KAJDACSYBALLA AA EFFECT OF THALIDOMIDE ON SERUM LEVELS OF IMMUNOGLOBULINS IGM AND IGA, RHEUMATOID-FACTOR AND ISOHEMAGLUTININS ANTI-A AND ANTI-B IN PATIENTS WITH LEPROMATOUS LEPROSY - A DOUBLE-BLIND-STUDY | 1 | 2 |
2444 | 8 | 11 | 1475 1998 REVUE DE MEDECINE INTERNE 19(3):196-198 Lair G; Marie I; Cailleux N; Blot E; Boullie MC; Courville P; Lauret P; Levesque H; Courtois H Langerhans cell histiocytosis in adult patients: cutaneous and mucous localizations improving with thalidomide | 9 | 13 |
2445 | 3 | 5 | 1476 1998 REVUE DE MEDECINE INTERNE 19(3):208-209 Grasland A; Pouchot J; Chaumaiziere D; Aitken G; Vinceneux P Effectiveness of thalidomide in cutaneous sarcoidosis | 3 | 4 |
2446 | 14 | 17 | 1599 1999 REVUE DE MEDECINE INTERNE 20(7):567-570 de Wazieres B; Gil H; Magy N; Berthier S; Vuitton DA; Dupond JL Treatment of recurrent oro-genital ulceration with low dose of thalidomide. Pilot study in 17 patients | 3 | 8 |
2447 | 16 | 18 | 2001 2001 REVUE DE MEDECINE INTERNE 22(1):5-7 Grosbois B; Duguet C Thalidomide: the revival | 2 | 4 |
2448 | 11 | 15 | 2285 2002 REVUE DE MEDECINE INTERNE 23(7):651-656 Claudon A; Dietemann JL; De Compte AH; Hassler P Interest of thalidomide in cutaneo-mucous and hypothalamo-hypophyseal in Langerhans cell histiocytosis. | 1 | 1 |
2449 | 9 | 11 | 2286 2002 REVUE DE MEDECINE INTERNE 23(8):724-727 Gachon J; Grob JJ; Richard MA Thalidomide treatment leading thrombotic events: two cases | 3 | 4 |
2450 | 2 | 6 | 861 1984 REVUE DU RHUMATISME 51(10):585-585 TREVES R; ARNAUD M; JACOB P; LUBEAU M; TABARAUD F; BURKI F; DESPROGESGOTTERON R DRAMATIC IMPROVEMENT IN THE ARTHRITIS OF BEHCETS-DISEASE FOLLOWING THE ADMINISTRATION OF THALIDOMIDE - A CASE-REPORT | 3 | 5 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2451 | 17 | 30 | 906 1985 REVUE NEUROLOGIQUE 141(11):719-728 CHAPON F; LECHEVALIER B; DASILVA DC; RIVRAIN Y; DUPUY B; DESCHAMPS P THALIDOMIDE INDUCED NEUROPATHY | 5 | 8 |
2452 | 10 | 48 | 2552 2003 RHEUMATIC DISEASE CLINICS OF NORTH AMERICA 29(3):481-+ Davis JC; Huang F; Maksymowych W New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate | 0 | 0 |
2453 | 14 | 41 | 2002 2001 RHEUMATOLOGY 40(8):933-938 Kari JA; Shah V; Dillon MJ Behcet's disease in UK children: clinical features and treatment including thalidomide | 5 | 14 |
2454 | 0 | 0 | 177 1962 ROYAL SOCIETY OF HEALTH JOURNAL 82(5):223-224 [Anon] THALIDOMIDE | 0 | 0 |
2455 | 0 | 0 | 259 1963 SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION 15(1):102-& NYSTROM C BIOCHEMICAL EFFECTS OF THALIDOMIDE - A PRELIMINARY REPORT | 8 | 12 |
2456 | 4 | 36 | 765 1981 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 13(6):553-562 SHANNON EJ; MIRANDA RO; MORALES MJ; HASTINGS RC INHIBITION OF DENOVO IGM ANTIBODY-SYNTHESIS BY THALIDOMIDE AS A RELEVANT MECHANISM OF ACTION IN LEPROSY | 32 | 41 |
2457 | 22 | 45 | 1162 1994 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 40(5):535-542 ARALACHAVES M; VILANOVA M; RIBEIRO A; PINTO J IMMUNOSTIMULATORY EFFECT OF THALIDOMIDE IN NORMAL C57BL/6 MICE IS COMPATIBLE WITH STIMULATION OF A HIGHLY CONNECTED CENTRAL IMMUNE-SYSTEM .1. | 4 | 6 |
2458 | 11 | 26 | 1163 1994 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 40(5):543-548 VILANOVA M; RIBEIRO A; CARNEIRO J; ARALACHAVES M THE EFFECTS OF THALIDOMIDE TREATMENT ON AUTOIMMUNE-PRONE NZB AND MRL MICE ARE CONSISTENT WITH STIMULATION OF THE CENTRAL IMMUNE-SYSTEM .2. | 4 | 5 |
2459 | 18 | 33 | 1477 1998 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 48(4):397-402 Zhu J; Deng GM; Diab A; Zwingenberger K; Bakhiet M; Link H Thalidomide prolongs experimental autoimmune neuritis in Lewis rats | 4 | 10 |
2460 | 43 | 95 | 2553 2003 SCHMERZ 17(3):204-+ Peuckmann V; Strumpf M; Zenz M; Bruera E Novel potential uses of thalidomide in the management of pain? A review of the literature | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2461 | 2 | 4 | 260 1963 SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT 93(44):1559-& FELISATI D; NODARI R EFFETS TOXIQUES ET TERATOGENIQUES DE LA THALIDOMIDE SUR LES FOETUS DE LAPIN | 5 | 7 |
2462 | 0 | 0 | 178 1962 SCIENCE 137(3529):497-& WOLFLE D THALIDOMIDE LESSON | 0 | 0 |
2463 | 3 | 12 | 261 1963 SCIENCE 139(355):110-& FRANK O; LEEVY CM; HUTNER SH; BAKER H; ZIFFER H; AARONSON S METABOLIC DEFICIENCIES IN PROTOZOA INDUCED BY THALIDOMIDE | 25 | 43 |
2464 | 3 | 7 | 262 1963 SCIENCE 139(356):1295-& LUCEY JF; BEHRMAN RE THALIDOMIDE - EFFECT UPON PROGNANCY IN RHESUS MONKEY | 17 | 37 |
2465 | 4 | 10 | 301 1964 SCIENCE 143(361):1343-& HIRSCHBERG E; BRYANT S; ULTMANN JE; OSNOS M THALIDOMIDE - EFFECTS ON ENZYMES OF GLUTAMIC ACID METABOLISM IN MICE | 6 | 8 |
2466 | 0 | 3 | 302 1964 SCIENCE 144(362):1583-& DIPAOLO JA; WENNER CE THALIDOMIDE - EFFECTS ON EHRLICH ASCITES TUMOR CELLS IN VITRO | 4 | 9 |
2467 | 8 | 13 | 303 1964 SCIENCE 146(364):1300-& DELAHUNT CS; LASSEN LJ THALIDOMIDE SYNDROME IN MONKEYS | 25 | 60 |
2468 | 9 | 18 | 408 1966 SCIENCE 153(3733):310-& FOX RR; SAWIN PB; CRARY DD; WUEST HM INTRAVENOUS INJECTION OF THALIDOMIDE IN PREGNANT RABBITS | 6 | 7 |
2469 | 3 | 4 | 409 1966 SCIENCE 154(3754):1362-& SCHUMACHER H; BLAKE D; GILLETTE J; WUEST HM; FOX RR THALIDOMIDE SOLUTIONS | 7 | 7 |
2470 | 0 | 0 | 579 1973 SCIENCE AND PUBLIC AFFAIRS-BULLETIN OF THE ATOMIC SCIENTISTS 29(3):40-41 GOLDSMIT.M THALIDOMIDE AFFAIR | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2471 | 0 | 0 | 679 1978 SCIENCES ET TECHNIQUES DE L ANIMAL DE LABORATOIRE 3(4):233-242 LANDSMANN F; COLLIN A; LAINE H; MAZUE G EMBRYOPATHIES INDUCED BY THALIDOMIDE IN MACACA-IRUS | 0 | 2 |
2472 | 2 | 4 | 179 1962 SCIENTIFIC AMERICAN 207(2):29-& TAUSSIG HB THALIDOMIDE SYNDROME | 7 | 15 |
2473 | 0 | 2 | 1385 1997 SCIENTIST 11(3):1-& Brown KS New uses for thalidomide yielding valuable lessons | 1 | 4 |
2474 | 1 | 1 | 1386 1997 SCIENTIST 11(3):8-8 Brown KS Researchers explore thalidomide's therapeutic potential | 0 | 0 |
2475 | 5 | 7 | 2003 2001 SCIENTIST 15(2):1-+ Lewis R The return of thalidomide | 0 | 1 |
2476 | 0 | 0 | 1221 1995 SEARCH 26(10):290-290 WESTMORE A HEREDITY OF THALIDOMIDE DEFORMITY DISPUTED | 0 | 0 |
2477 | 0 | 0 | 1387 1997 SEARCH 28(8):239-239 [Anon] Inheriting thalidomide deformities | 0 | 0 |
2478 | 21 | 38 | 832 1983 SEMAINE DES HOPITAUX 59(45):3101-3104 BELAUBE P; GARCIN G; MARCHAND JP; PRIVAT Y SHOULD THALIDOMIDE BE REHABILITATED | 4 | 7 |
2479 | 79 | 87 | 1478 1998 SEMINARS IN CUTANEOUS MEDICINE AND SURGERY 17(4):231-242 Stirling DI Thalidomide and its impact in dermatology | 14 | 17 |
2480 | 9 | 27 | 1784 2000 SEMINARS IN HEMATOLOGY 37(1):1-4 Anderson KC Thalidomide: Therapeutic potential in hematologic malignancies | 6 | 8 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2481 | 61 | 96 | 1785 2000 SEMINARS IN HEMATOLOGY 37(1):5-14 Stirling DI Pharmacology of thalidomide | 21 | 23 |
2482 | 3 | 15 | 1786 2000 SEMINARS IN HEMATOLOGY 37(1):15-21 Munshi NC; Desikan KR; Barlogie B Clinical experience with thalidomide in multiple myeloma: Phase II trial results in refractory disease and ongoing studies | 5 | 6 |
2483 | 0 | 10 | 1787 2000 SEMINARS IN HEMATOLOGY 37(1):22-25 Alexanian R; Weber D Thalidomide for resistant and relapsing myeloma | 22 | 26 |
2484 | 8 | 35 | 1788 2000 SEMINARS IN HEMATOLOGY 37(1):26-34 Thomas DA Pilot studies of thalidomide in acute myelogenous leukemia, myelodysplastic syndromes, and myeloproliferative disorders | 9 | 13 |
2485 | 5 | 42 | 1789 2000 SEMINARS IN HEMATOLOGY 37(1):35-39 Alexanian R; Anderson KC; Barlogie B; Stirling DI; Thomas DA Thalidomide in hematologic malignancies: Future directions | 5 | 5 |
2486 | 6 | 48 | 2004 2001 SEMINARS IN HEMATOLOGY 38(3):250-259 Barlogie B; Zangari M; Spencer T; Fassas A; Anaissie E; Badros A; Cromer J; Tricot G Thalidomide in the management of multiple myeloma | 18 | 31 |
2487 | 7 | 20 | 2554 2003 SEMINARS IN HEMATOLOGY 40(4):1-2 Barlogie B Introduction: Thalidomide and the IMiDs in multiple myeloma | 0 | 0 |
2488 | 12 | 17 | 2555 2003 SEMINARS IN HEMATOLOGY 40(4):3-7 Alexanian R; Weber D; Anagnostopoulos A; Delasalle K; Wang M; Rankin K Thalidomide with or without dexamethasone for refractory or relapsing multiple myeloma | 0 | 0 |
2489 | 14 | 23 | 2556 2003 SEMINARS IN HEMATOLOGY 40(4):8-16 Dimopoulos MA; Anagnostopoulos A Thalidomide in relapsed/refractory multiple myeloma: Pivotal trials conducted outside the United States | 0 | 0 |
2490 | 10 | 33 | 2557 2003 SEMINARS IN HEMATOLOGY 40(4):17-22 Rajkumar SV Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2491 | 11 | 14 | 2558 2003 SEMINARS IN HEMATOLOGY 40(4):33-38 Barlogie B Thalidomide and CC-5013 in multiple myeloma: The University of Arkansas experience | 0 | 0 |
2492 | 10 | 40 | 2005 2001 SEMINARS IN ONCOLOGY 28(4):62-66 Figg WD; Arlen P; Gulley J; Fernandez P; Noone M; Fedenko K; Hamilton M; Parker C; Kruger EA; Pluda J; Dahut WL A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer | 15 | 37 |
2493 | 8 | 18 | 2006 2001 SEMINARS IN ONCOLOGY 28(6):577-582 Barlogie B; Tricot G; Anaissie E Thalidomide in the management of multiple myeloma | 10 | 17 |
2494 | 7 | 21 | 2007 2001 SEMINARS IN ONCOLOGY 28(6):583-587 Kyle RA; Rajkumar SV Therapeutic application of thalidomide in multiple myeloma | 5 | 9 |
2495 | 6 | 18 | 2008 2001 SEMINARS IN ONCOLOGY 28(6):588-592 Blade J; Esteve J; Rosinol L; Perales M; Montoto S; Tuset M; Montserrat E Thalidomide in refractory and relapsing multiple myeloma | 11 | 13 |
2496 | 12 | 25 | 2009 2001 SEMINARS IN ONCOLOGY 28(6):593-596 Desikan RK; Jagannath S Therapeutic dilemmas with thalidomide in multiple myeloma: Case discussions | 2 | 2 |
2497 | 22 | 47 | 2010 2001 SEMINARS IN ONCOLOGY 28(6):597-601 D'Amato RJ; Lentzsch S; Anderson KC; Rogers MS Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma | 0 | 10 |
2498 | 16 | 17 | 2011 2001 SEMINARS IN ONCOLOGY 28(6):602-606 Stirling D Thalidomide: A novel template for anticancer drugs | 7 | 12 |
2499 | 5 | 31 | 2287 2002 SEMINARS IN ONCOLOGY 29(6):34-38 Durie BGM Low-dose thalidomide in myeloma: Efficacy and biologic significance | 5 | 7 |
2500 | 6 | 25 | 2559 2003 SEMINARS IN ONCOLOGY 30(2):265-269 Dimopoulos MA; Tsatalas C; Zomas A; Hamilos G; Panayiotidis P; Margaritis D; Matsouka C; Economopoulos T; Anagnostopoulos N Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone | 2 | 3 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2501 | 7 | 29 | 2560 2003 SEMINARS IN ONCOLOGY 30(2):270-274 Coleman M; Leonard J; Lyons L; Szelenyi H; Niesvizky R Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone | 3 | 5 |
2502 | 15 | 35 | 1600 1999 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 12(6):305-311 Monastirli A; Georgiou S; Bolsen K; Pasmatzi E; Papapanagiotou A; Goerz G; Kalofoutis A; Merk HF; Tsambaos D Treatment of porphyria cutanea tarda with oral thalidomide | 5 | 6 |
2503 | 11 | 30 | 1601 1999 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 12(6):312-316 Kalofoutis A; Monastirli A; Papapanagiotou A; Georgiou S; Pasmatzi E; Sakkis T; Bolsen K; Goerz G; Merk HF; Tsambaos D Alterations of rat liver phospholipid composition induced by oral thalidomide | 0 | 0 |
2504 | 8 | 12 | 2561 2003 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 16(2):123-129 Hadgraft J; Goosen C; du Plessis J; Flynn G Predicting the dermal absorption of thalidomide and its derivatives | 0 | 0 |
2505 | 0 | 6 | 1296 1996 SLEEP 19(2):116-116 Kanbayashi T; Nishino S; Tafti M; Hishikawa Y; Dement WC; Mignot E Thalidomide, immune modulation and narcolepsy | 0 | 2 |
2506 | 5 | 11 | 1602 1999 SLEEP 22(1):113-115 Kanbayashi T; Shimizu T; Takahashi Y; Kitajima T; Takahashi K; Saito Y; Hishikawa Y Thalidomide increases both REM and stage 3-4 sleep in human adults: A preliminary study | 8 | 10 |
2507 | 0 | 1 | 580 1973 SOCIAL CASEWORK 54(7):430-431 DESAIX CC ABNORMALITY AND NORMALITY - MOTHERING OF THALIDOMIDE CHILDREN - ROSKIES,E | 0 | 0 |
2508 | 0 | 0 | 263 1963 SOCIAL EDUCATION 27(3):131-133 WOODWORTH JR THALIDOMIDE IN RETROSPECT | 0 | 0 |
2509 | 3 | 83 | 2288 2002 SOCIAL HISTORY OF MEDICINE 15(1):137-158 Daemmrich A A tale of two experts: Thalidomide and political engagement in the United States and West Germany | 0 | 0 |
2510 | 0 | 1 | 581 1973 SOCIAL SCIENCE & MEDICINE 7(2):161-162 SHEPHERD J ABNORMALITY AND NORMALITY - MOTHERING OF THALIDOMIDE CHILDREN - ROSKIES,E | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2511 | 0 | 68 | 1790 2000 SOCIAL STUDIES OF SCIENCE 30(1):41-71 Timmermans S; Leiter V The redemption of thalidomide: Standardizing the risk of birth defects | 0 | 1 |
2512 | 7 | 34 | 1113 1993 SPECTROSCOPY LETTERS 26(4):597-619 ROTHCHILD R; SANDERS K; VENKATASUBBAN KS NMR-STUDIES OF DRUGS - USE OF LANTHANIDE SHIFT-REAGENTS IN POLAR-SOLVENT WITH THALIDOMIDE | 0 | 6 |
2513 | 5 | 24 | 443 1967 SPERIMENTALE 117(6):465-& LAI P; PALMIERI G TERATOGENIC EFFECTS OF THALIDOMIDE IN CHICKEN AND RABBIT | 0 | 0 |
2514 | 20 | 40 | 1603 1999 SURGERY 125(5):536-544 Kotoh T; Dhar DK; Masunaga R; Tabara H; Tachibana M; Kubota H; Kohno H; Nagasue N Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice | 12 | 27 |
2515 | 3 | 4 | 2012 2001 SWISS MEDICAL WEEKLY 131(9-10):133-133 Trojan A; Anagnostara A; Fost L Thalidomide: near complete regression of extramedullary bulk in refractory multiple myeloma | 2 | 2 |
2516 | 77 | 104 | 2562 2003 SWISS MEDICAL WEEKLY 133(5-6):77-87 von Moos R; Stolz R; Cerny T; Gillessen S Thalidomide: from tragedy to promise | 1 | 1 |
2517 | 6 | 27 | 2013 2001 SYNTHESIS-STUTTGART (7):999-1000 Seijas JA; Vazquez-Tato MP; Gonzalez-Bande C; Martinez MM; Pacios-Lopez B Microwave promoted synthesis of a rehabilitated drug: Thalidomide | 0 | 2 |
2518 | 4 | 19 | 2563 2003 SYNTHETIC COMMUNICATIONS 33(8):1375-1382 Chang MY; Chen ST; Chang NC A synthesis of racemic thalidomide | 0 | 4 |
2519 | 0 | 0 | 582 1973 TEACHER OF THE DEAF 71(419):215-216 ALLEN G ARTIFICIAL EARS FOR A PROFOUNDLY DEAF THALIDOMIDE CHILD | 0 | 0 |
2520 | 6 | 12 | 907 1985 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 5(3):149-158 BRAUN AG; WEINREB SL TERATOGEN METABOLISM - SPONTANEOUS DECAY PRODUCTS OF THALIDOMIDE AND THALIDOMIDE ANALOGS ARE NOT BIOACTIVATED BY LIVER-MICROSOMES | 11 | 15 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2521 | 10 | 38 | 1029 1990 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 10(4):281-294 HUANG PHT; MCBRIDE WG THALIDOMIDE INDUCED ALTERATION IN SECONDARY STRUCTURE OF RAT EMBRYONIC DNA INVIVO | 6 | 12 |
2522 | 7 | 20 | 1164 1994 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 14(3):115-122 HEGER W; SCHMAHL HJ; KLUG S; FELIES A; NAU H; MERKER HJ; NEUBERT D EMBRYOTOXIC EFFECTS OF THALIDOMIDE DERIVATIVES IN THE NONHUMAN PRIMATE CALLITHRIX-JACCHUS .4. TERATOGENICITY OF MU-G/KG DOSES OF THE EM12 ENANTIOMERS | 7 | 15 |
2523 | 7 | 13 | 1388 1997 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 17(1):1-5 Huang PHT; McBride WG Interaction of [glutarimide-2-C-14]-thalidomide with rat embryonic DNA in vivo | 7 | 12 |
2524 | 7 | 11 | 1389 1997 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 17(1):R1-R2 Neubert D Never-ending tales of the mode of the teratogenic action of thalidomide | 3 | 5 |
2525 | 10 | 37 | 1791 2000 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 20(1):35-47 Fort DJ; Stover EL; Bantle JA; Finch RA Evaluation of the developmental toxicity of thalidomide using Frog Embryo Teratogenesis Assay-Xenopus (FETAX): Biotransformation and detoxification | 6 | 8 |
2526 | 16 | 22 | 1792 2000 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 20(5):301-311 Teo S; Morgan M; Stirling D; Thomas S Assessment of the in vitro and in vivo genotoxicity of Thalomid (R) (Thalidomide) | 1 | 1 |
2527 | 0 | 0 | 470 1968 TERATOLOGY 1(2):217-& KATZ C; FRASER FC POSSIBLE INTERACTION OF 6-AMINONICOTINAMIDE AND THALIDOMIDE | 0 | 0 |
2528 | 0 | 2 | 471 1968 TERATOLOGY 1(2):223-& WUEST HM; TARNOWSK.S TOXICITY OF OPTICAL ACTIVE FORMS OF THALIDOMIDE | 0 | 0 |
2529 | 3 | 28 | 472 1968 TERATOLOGY 1(3):235-& GLOBUS M; GIBSON MA A HISTOLOGICAL AND HISTOCHEMICAL STUDY OF DEVELOPMENT OF STERNUM IN THALIDOMIDE-TREATED RATS | 6 | 18 |
2530 | 0 | 1 | 489 1969 TERATOLOGY 2(3):265-& MCNULTY WP; WUEST HM THALIDOMIDE, TERATOGENY, AND STRUCTURE - TERATOGENIC ACTION OF WU 385 ON RHESUS | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2531 | 0 | 0 | 490 1969 TERATOLOGY 2(3):269-& SCHUMACHER H; WILSON JG DISPOSITION OF THALIDOMIDE IN REHESUS MONKEY | 0 | 0 |
2532 | 0 | 3 | 491 1969 TERATOLOGY 2(3):273-& WUEST HM; FOX RR; CRARY DD THALIDOMIDE - LACK OF TERATOGENIC ACTION OF N-CARBETHOXYPHTHALIMIDE (WU374) IN NEW ZEALAND RABBIT | 0 | 0 |
2533 | 0 | 0 | 511 1970 TERATOLOGY 3(2):203-& KELLER GR; BLAKE DA COMPARATIVE STUDIES OF ORAL ABSORPTION OF H-3-THALIDOMIDE | 0 | 0 |
2534 | 0 | 0 | 512 1970 TERATOLOGY 3(2):211-& WYNN RL; BLAKE DA A METABOLITE OF THALIDOMIDE HAVING POSSIBLE TERATOLOGICAL SIGNIFICANCE | 0 | 0 |
2535 | 14 | 26 | 531 1971 TERATOLOGY 4(1):75-& KELLER GR; BLAKE DA COMPARATIVE STUDIES ON ABSORPTION OF H-3 THALIDOMIDE IN RABBITS AND RATS | 1 | 3 |
2536 | 0 | 0 | 532 1971 TERATOLOGY 4(2):231-& HENDRICK.AG TERATOGENIC EFFECTS OF THALIDOMIDE IN BONNET MONKEY (MACACA-RADIATA) AND CYNOMOLGUS MONKEY (MACACA-IRUS) | 0 | 2 |
2537 | 0 | 0 | 533 1971 TERATOLOGY 4(2):247-& TANIMURA T; TANAKA O; NISHIMUR.H EFFECTS OF THALIDOMIDE AND QUINE DIHYDROCHLORIDE ON JAPANESE AND RHESUS MONKEY EMBRYOS | 2 | 5 |
2538 | 14 | 36 | 534 1971 TERATOLOGY 4(4):409-& NUDLEMAN KL; TRAVILL AA MORPHOLOGICAL AND HISTOCHEMICAL STUDY OF THALIDOMIDE-INDUCED UPPER LIMB MALFORMATIONS IN RABBIT FETUSES | 3 | 10 |
2539 | 0 | 0 | 535 1971 TERATOLOGY 4(4):495-& NEUBERT D; TESKE S; ENGELS K INHIBITION OF PROTOCOLLAGEN PROLINHYDROXYLASE BY HYDROLYSIS PRODUCTS OF THALIDOMIDE | 0 | 0 |
2540 | 5 | 12 | 560 1972 TERATOLOGY 5(2):233-& SCHUMACHER HJ; WILSON JG; TERAPANE J; JORDAN RR TERATOGENIC ACTIVITY OF A THALIDOMIDE ANALOG, EM12, IN RABBITS, RATS, AND MONKEYS | 14 | 32 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2541 | 0 | 0 | 561 1972 TERATOLOGY 5(2):257-& HENDRICK.AG; NEWMAN L TEMPORAL AND MANDIBULAR BONE MALFORMATIONS INDUCED BY THALIDOMIDE IN BONNET MONKEY (M RADIATA) | 0 | 4 |
2542 | 0 | 0 | 562 1972 TERATOLOGY 6(1):110-& KIDA M STUDY OF DIAGNOSTIC STANDARD ON THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2543 | 8 | 24 | 583 1973 TERATOLOGY 7(2):151-& HENDRICK.AG; NEWMAN L APPENDICULAR SKELETAL AND VISCERAL MALFORMATIONS INDUCED BY THALIDOMIDE IN BONNET MONKEYS | 0 | 19 |
2544 | 0 | 0 | 584 1973 TERATOLOGY 7(3):A28-A28 STAPLES RE; KLUMPP G TERATOGENIC RESPONSE TO LOW DOSAGES OF THALIDOMIDE IN RABBIT | 0 | 0 |
2545 | 4 | 7 | 585 1973 TERATOLOGY 8(2):163-166 KAJII T; KIDA M; TAKAHASH.K EFFECT OF THALIDOMIDE INTAKE DURING 113 HUMAN PREGNANCIES | 8 | 21 |
2546 | 0 | 0 | 586 1973 TERATOLOGY 8(2):225-225 KAJII T; KIDA M; TAKAHASH.K THALIDOMIDE AND CRITICAL PERIOD - PRESCRIPTION FOR 113 PREGNANT-WOMEN | 0 | 0 |
2547 | 0 | 0 | 587 1973 TERATOLOGY 8(2):242-242 WUEST HM; MCNULTY WP EXPERIMENTAL TERATOLOGY AND THALIDOMIDE PROBLEM | 0 | 0 |
2548 | 0 | 0 | 602 1974 TERATOLOGY 9(3):A24-A25 KHERA KS; HEGGTVEI.MA FETAL CARDIOVASCULAR DEFECTS INDUCED BY THALIDOMIDE IN CAT | 0 | 0 |
2549 | 0 | 0 | 603 1974 TERATOLOGY 9(3):A27-A28 MCBRIDE WG HISTOLOGICAL STUDY OF NEURONS OF DORSAL ROOT GANGLIA IN OFFSPRING OF PREGNANT RABBITS TREATED WITH THALIDOMIDE AND OTHER AGENTS | 0 | 0 |
2550 | 2 | 13 | 604 1974 TERATOLOGY 10(3):283-291 MCBRIDE WG FETAL NERVE-CELL DEGENERATION PRODUCED BY THALIDOMIDE IN RABBITS | 11 | 28 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2551 | 0 | 0 | 605 1974 TERATOLOGY 10(3):317-317 MCBRIDE WG HISTOLOGICAL STUDY OF NEURONS OF DORSAL ROOT GANGLIA IN OFFSPRING OF PREGNANT RABBITS TREATED WITH THALIDOMIDE AND OTHER AGENTS | 0 | 0 |
2552 | 2 | 11 | 616 1975 TERATOLOGY 11(1):65-72 KHERA KS FETAL CARDIOVASCULAR AND OTHER DEFECTS INDUCED BY THALIDOMIDE IN CATS | 0 | 8 |
2553 | 0 | 0 | 631 1976 TERATOLOGY 13(2):A29-A29 MANSON JM; SMITH CC EFFECTS OF THALIDOMIDE, EM-8 AND EM12 ON INVITRO DEVELOPMENT OF EMBRYONIC MOUSE LIMBS | 0 | 0 |
2554 | 0 | 0 | 632 1976 TERATOLOGY 13(2):A39-A39 THEISEN CT; SCHMIDT LH; WILSON JG ANATOMY OF THALIDOMIDE DYSMELIA IN RHESUS-MONKEYS | 0 | 0 |
2555 | 6 | 20 | 633 1976 TERATOLOGY 14(1):71-87 MCBRIDE WG STUDIES OF ETIOLOGY OF THALIDOMIDE DYSMORPHOGENESIS | 6 | 28 |
2556 | 0 | 0 | 634 1976 TERATOLOGY 14(2):243-243 KIDA M; TSUCHIYA K; ARIMA M; SUGIURA Y DIFFERENTIAL-DIAGNOSIS OF LIMB REDUCTION MALFORMATIONS INCLUDING THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2557 | 0 | 1 | 656 1977 TERATOLOGY 15(2):A24-A24 THEISEN CT; HABIGER T; SWARTWOOD LD; SCHMIDT HL; WILSON JG THALIDOMIDE DYSMELIA IN RHESUS-MONKEYS - EVIDENCE FOR A PRIMARY EFFECT ON SPINAL GANGLIA | 1 | 3 |
2558 | 0 | 0 | 657 1977 TERATOLOGY 15(2):A24-A25 BAZZOLI AS; SCOTT WJ; MANSON J; WILSON JG THALIDOMIDE INDUCED LIMB MALFORMATIONS IN REGENERATING NEWT FORELIMB | 0 | 1 |
2559 | 14 | 24 | 658 1977 TERATOLOGY 16(1):79-82 MCBRIDE WG THALIDOMIDE EMBRYOPATHY | 11 | 29 |
2560 | 0 | 0 | 659 1977 TERATOLOGY 16(1):102-102 ASAKA A; SAITO T; NAGASAWA M; KANNO T; KIDA M NEUROPSYCHIATRIC INVOLVEMENT IN PATIENTS WITH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2561 | 0 | 0 | 660 1977 TERATOLOGY 16(1):111-111 KIDA M; HAYASHI H; TANAKA Y; MATSUMOTO Y; IWAKURA H; ASAKA A; ARIMOTO H; GOMI S HEALTH-CARE SYSTEM FOR THALIDOMIDE EMBRYOPATHY .1. | 0 | 0 |
2562 | 3 | 8 | 661 1977 TERATOLOGY 16(3):333-335 SCOTT WJ; FRADKIN R; WILSON JG NON-CONFIRMATION OF THALIDOMIDE INDUCED TERATOGENESIS IN RATS AND MICE | 18 | 32 |
2563 | 0 | 0 | 680 1978 TERATOLOGY 17(2):A23-A23 THEISEN CT; SCHMIDT LH; WILSON JG UNUSUAL MUSCLE ABNORMALITIES PRODUCED BY THALIDOMIDE IN RHESUS-MONKEYS | 0 | 1 |
2564 | 0 | 0 | 681 1978 TERATOLOGY 17(2):A42-A42 MCCREDIE J MECHANISM OF TERATOGENICITY COMMON TO THALIDOMIDE EMBRYOPATHY AND OTHER DYSMELIC SYNDROMES | 0 | 0 |
2565 | 0 | 0 | 682 1978 TERATOLOGY 18(1):136-136 YASUDA M EMBRYOLOGY OF THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2566 | 0 | 0 | 683 1978 TERATOLOGY 18(1):137-137 SUGIURA Y ROENTGENOGRAPHIC CLASSIFICATION OF REDUCTION ANOMALIES OF UPPER LIMBS IN THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2567 | 0 | 0 | 684 1978 TERATOLOGY 18(1):137-137 KIDA M MEDICAL BACKGROUND OF THALIDOMIDE-EMBRYOPATHY | 0 | 0 |
2568 | 0 | 0 | 685 1978 TERATOLOGY 18(1):137-137 ICHIBANGASE Y SOCIAL-PROBLEMS OF THALIDOMIDE CASES | 0 | 0 |
2569 | 0 | 0 | 686 1978 TERATOLOGY 18(1):149-149 HIRAYAMA M; NAKAYAMA T; ESAKI K EFFECTS OF THALIDOMIDE ON BEAGLE EMBRYOS | 0 | 0 |
2570 | 0 | 24 | 687 1978 TERATOLOGY 18(3):393-403 HENDRICKX AG; SAWYER RH DEVELOPMENTAL STAGING AND THALIDOMIDE TERATOGENICITY IN GREEN MONKEY (CERCOPITHECUS-AETHIOPS) | 3 | 16 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2571 | 6 | 9 | 710 1979 TERATOLOGY 19(1):129-129 CHAMBERLAIN JG THALIDOMIDE AND LACK OF TERATOGENESIS IN LONG-EVANS RATS | 0 | 1 |
2572 | 0 | 0 | 711 1979 TERATOLOGY 19(2):A51-A51 THEISEN CT; SPENCER MP MORPHOLOGICAL OBSERVATIONS IN RHESUS-MONKEY EMBRYOS FOLLOWING MATERNAL THALIDOMIDE ADMINISTRATION | 2 | 3 |
2573 | 10 | 28 | 712 1979 TERATOLOGY 19(3):313-& THEISEN CT; BODIN JD; SVOBODA JA; PETTINELLI MW UNUSUAL MUSCLE ABNORMALITIES ASSOCIATED WITH THALIDOMIDE TREATMENT IN A RHESUS-MONKEY - CASE-REPORT | 0 | 2 |
2574 | 2 | 8 | 713 1979 TERATOLOGY 19(3):341-344 JACKSON AJ; SCHUMACHER HJ TERATOGENIC ACTIVITY OF A THALIDOMIDE ANALOGOUS EM12 IN RATS ON A LOW-ZINC DIET | 2 | 25 |
2575 | 0 | 0 | 714 1979 TERATOLOGY 20(1):176-177 ASAKA A; KIDA M THALIDOMIDE EMBRYOPATHY IN TWINS | 0 | 0 |
2576 | 0 | 0 | 732 1980 TERATOLOGY 21(2):A29-A29 BRAUN AG; DAILEY JP THALIDOMIDE METABOLITE INHIBITS TUMOR-CELL ATTACHMENT TO LECTIN COATED SURFACES | 0 | 1 |
2577 | 0 | 0 | 733 1980 TERATOLOGY 21(2):A50-A51 KLEIN NW; PARKER RM; PLENEFISCH JD INVITRO CULTURE OF RAT EMBRYOS ON MONKEY SERUM - EFFECTS OF MENSTRUAL-CYCLE AND THALIDOMIDE CONSUMPTION | 1 | 2 |
2578 | 0 | 0 | 734 1980 TERATOLOGY 21(2):A71-A71 SPENCER MP; THEISEN CT THALIDOMIDE AND DEVELOPMENT OF SENSORY GANGLIA | 0 | 0 |
2579 | 0 | 0 | 735 1980 TERATOLOGY 21(2):A72-A72 THEISEN CT THALIDOMIDE DYSMELIA - PROPOSED PATHOGENESIS | 0 | 1 |
2580 | 0 | 0 | 736 1980 TERATOLOGY 22(1):A32-A32 KIDA M; KIKUCHI H; TANAKA M; MATSUMOTO Y; IWAKURA H; ARIMOTO H; ASAKA A; SAITO T SYMPTOMS SEEN IN 76 PATIENTS WITH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2581 | 0 | 13 | 737 1980 TERATOLOGY 22(2):179-182 HENDRICKX AG; HELM FC NON-TERATOGENICITY OF A STRUCTURAL ANALOG OF THALIDOMIDE IN PREGNANT BABOONS (PAPIO-CYNOCEPHALUS) | 7 | 15 |
2582 | 0 | 7 | 738 1980 TERATOLOGY 22(2):183-185 SCOTT WJ; WILSON JG; HELM FC A METABOLITE OF A STRUCTURAL ANALOG OF THALIDOMIDE LACKS TERATOGENIC EFFECT IN PREGNANT RHESUS-MONKEYS | 7 | 9 |
2583 | 0 | 0 | 766 1981 TERATOLOGY 23(2):A51-A51 MCCREDIE J THALIDOMIDE AND THE NEURAL CREST | 0 | 0 |
2584 | 0 | 0 | 767 1981 TERATOLOGY 23(2):A63-A64 STEPHENS TD; MCNULTY TR IS THALIDOMIDE EMBRYOPATHY A RESULT OF NEUROPATHY - NO | 0 | 0 |
2585 | 0 | 0 | 768 1981 TERATOLOGY 23(2):A65-A65 THEISEN CT; MCGREGOR EE FURTHER OBSERVATIONS ON THE DEVELOPMENT OF THALIDOMIDE INDUCED LIMB DEFORMITIES | 4 | 7 |
2586 | 4 | 40 | 769 1981 TERATOLOGY 23(3):351-364 NEWMAN LM; HENDRICKX AG FETAL EAR MALFORMATIONS INDUCED BY MATERNAL INGESTION OF THALIDOMIDE IN THE BONNET MONKEY (MACACA, RADIATA) | 2 | 13 |
2587 | 0 | 0 | 788 1982 TERATOLOGY 25(2):A28-A29 BLAKE DA; GORDON GB; SPIELBERG SP THE ROLE OF METABOLIC-ACTIVATION IN THALIDOMIDE TERATOGENESIS | 0 | 0 |
2588 | 1 | 2 | 789 1982 TERATOLOGY 25(2):A40-A40 FLINT OP THE EFFECT OF THALIDOMIDE ON MICROMASS CULTURES OF EMBRYONIC RAT-CELLS | 0 | 0 |
2589 | 0 | 0 | 790 1982 TERATOLOGY 25(2):A47-A47 HELM FC; FRANKUS E CHEMICAL-STRUCTURE AND TERATOGENIC ACTIVITY OF THALIDOMIDE-RELATED COMPOUNDS | 4 | 4 |
2590 | 0 | 0 | 791 1982 TERATOLOGY 25(2):A61-A61 MCBRIDE WG; VARDY P; STOKES PA THE MECHANISM OF THALIDOMIDE TERATOGENISM IN THE RABBIT LIMB | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2591 | 0 | 0 | 792 1982 TERATOLOGY 25(2):A75-A75 SHEPARD TH; SHIOTA K BIOACTIVATION OF THALIDOMIDE BY A MONKEY LIVER FRACTION IN A RAT LIMB CULTURE SYSTEM | 0 | 0 |
2592 | 0 | 0 | 793 1982 TERATOLOGY 26(1):A4-A4 TSUCHIYA K THALIDOMIDE EMBRYOPATHY AND ITS ALLIED CONDITIONS IN JAPAN | 0 | 0 |
2593 | 0 | 0 | 794 1982 TERATOLOGY 26(1):A17-A17 MIKAMI T; MATSUBARA Y; YAMANAKA H; SUZUKI Y TERATOGENIC EFFECTS OF THALIDOMIDE IN RABBITS - (3) THE DEVELOPMENTAL PROCESSES OF DYSRAPHIC MALFORMATIONS IN JW-NIBS RABBITS | 0 | 0 |
2594 | 0 | 0 | 795 1982 TERATOLOGY 26(3):A19-A19 OCKENFELS H; KOCHERBECKER U; KOCHER W EFFECTS OF SINGLE AND COMBINED ACTION OF A HYDROLYSIS PRODUCT OF THALIDOMIDE AND THE SURFACTANT TWEEN 20 IN MICE | 0 | 0 |
2595 | 0 | 6 | 833 1983 TERATOLOGY 27(2):A29-A30 BECK SL PAUCITY OF POSTNATAL EFFECTS ON CD-1 MOUSE SKELETON OF PRENATAL EXPOSURE TO CAPTAN, THALIDOMIDE, CORTISONE, OR DIPHENYLHYDANTOIN | 0 | 3 |
2596 | 0 | 0 | 834 1983 TERATOLOGY 27(2):A33-A33 BRAUN AG; WEINREB SL METABOLITES OF THALIDOMIDE ANALOGS INHIBIT ATTACHMENT OF CELLS TO CONCANAVALIN A COATED SURFACES | 0 | 2 |
2597 | 0 | 0 | 835 1983 TERATOLOGY 27(2):A80-A80 THEISEN CT THALIDOMIDE DYSMELIA IN RHESUS-MONKEYS - AN OVERVIEW | 0 | 0 |
2598 | 11 | 29 | 836 1983 TERATOLOGY 27(3):327-332 PARKHIE M; WEBB M EMBRYOTOXICITY AND TERATOGENICITY OF THALIDOMIDE IN RATS | 3 | 7 |
2599 | 0 | 0 | 837 1983 TERATOLOGY 28(1):A13-A14 MIKAMI T; MATSUBARA Y; YAMANAKA H; SUZUKI Y TERATOGENIC EFFECTS OF THALIDOMIDE IN RABBITS .4. DYSRAPHISM OF THE ANTERIOR NEUROPORE IN JW-NIBS RABBIT EMBRYOS ANALYZED BY SEM | 0 | 0 |
2600 | 0 | 0 | 862 1984 TERATOLOGY 29(2):A19-A20 BRAUN AG; COLLINS M; HARDING F; WEINREB S FACTORS INFLUENCING THE ACTIVATION OF THALIDOMIDE TO A PRODUCT INHIBITING ATTACHMENT OF TUMOR-CELLS TO LECTIN COATED SURFACES | 0 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2601 | 0 | 0 | 863 1984 TERATOLOGY 30(1):A26-A26 KANNO O; SAITO T; ASAKA A ELECTROENCEPHALOGRAPHIC STUDY ON THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2602 | 0 | 0 | 864 1984 TERATOLOGY 30(1):A26-A26 IWAKURA H; YOSHIDA K; OGAWA T PHYSICAL-EXAMINATION OF THALIDOMIDE EMBRYOPATHY PATIENTS - PROBLEMS OF MOTOR DYSFUNCTION | 0 | 0 |
2603 | 0 | 0 | 865 1984 TERATOLOGY 30(1):A26-A27 SAITO T; ASAKA A; KANNO O; KIDA M PSYCHOLOGICAL-TESTS AND A STUDY OF SOCIAL-ADJUSTMENT OF PATIENTS WITH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2604 | 0 | 0 | 866 1984 TERATOLOGY 30(1):A27-A27 KIDA M MEDICAL-EXAMINATION OF THALIDOMIDE-EMBRYOPATHY - METHODOLOGY AND SUMMARY | 0 | 0 |
2605 | 0 | 0 | 867 1984 TERATOLOGY 30(1):A36-A36 TANAKA Y THALIDOMIDE-INDUCED OTOLARYNGOLOGICAL DEFECTS | 0 | 0 |
2606 | 0 | 0 | 868 1984 TERATOLOGY 30(1):A36-A36 ARIMOTO H OCULAR FINDINGS OF THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2607 | 0 | 0 | 869 1984 TERATOLOGY 30(1):A36-A36 MATSUMOTO Y; HAMADA Y FINDINGS OF THE UROGENITAL ORGAN SYSTEMS OF THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2608 | 0 | 0 | 870 1984 TERATOLOGY 30(1):A37-A37 KIKUCHI S ANOMALIES OF THE ORAL AND MAXILLO-FACIAL REGIONS IN THALIDOMIDE EMBRYOPATHY (JAPAN) | 0 | 0 |
2609 | 0 | 0 | 908 1985 TERATOLOGY 31(3):A68-A68 TESH JM; NEWALL DR TERATOGENIC EFFECTS OF THALIDOMIDE ON RAT EMBRYOS INVITRO | 0 | 1 |
2610 | 13 | 38 | 909 1985 TERATOLOGY 32(1):133-144 NEWMAN CGH TERATOGEN UPDATE - CLINICAL ASPECTS OF THALIDOMIDE EMBRYOPATHY - A CONTINUING PREOCCUPATION | 8 | 27 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2611 | 0 | 0 | 931 1986 TERATOLOGY 33(2):A48-A49 TESH JM; NEWALL DR THALIDOMIDE AND ABNORMAL EMBRYONIC-DEVELOPMENT INVITRO | 0 | 0 |
2612 | 0 | 0 | 932 1986 TERATOLOGY 33(2):A57-A57 SCHMAHL HJ; WINKLER K; HEGER W; BARRACH HJ; NAU H PHARMACOKINETICS OF THE TERATOGENIC AND NONTERATOGENIC THALIDOMIDE ANALOGS EM-12 AND SUPIDIMID IN THE RAT AND MARMOSET MONKEY | 0 | 0 |
2613 | 0 | 0 | 933 1986 TERATOLOGY 34(3):415-415 HEGER W; SAMES K; MERKER HJ; FRANKUS E; GRAUDUMS I; NEUBERT D TERATOGENIC EVALUATION OF A METHYLATED THALIDOMIDE DERIVATIVE IN A PRIMATE SPECIES | 0 | 0 |
2614 | 0 | 0 | 950 1987 TERATOLOGY 35(2):A73-A73 HALES BF; JAIN R SPECIES-DIFFERENCES IN THE EFFECTS OF DRUG-METABOLIZING-ENZYMES ON THE TERATOGENICITY OF THALIDOMIDE IN RAT EMBRYO CULTURES | 0 | 1 |
2615 | 0 | 0 | 951 1987 TERATOLOGY 36(1):A8-A9 DEIONGH RU; MCCREDIE J QUANTITATIVE NEUROPATHOLOGY OF THE PERIPHERAL-NERVES IN RABBIT THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2616 | 0 | 0 | 952 1987 TERATOLOGY 36(3):435-435 KIDA M A QUARTER CENTURY IN THE THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2617 | 0 | 0 | 978 1988 TERATOLOGY 38(2):199-199 MCBRIDE WG; CATALANO A; DUGUID P; HICKS L THE EFFECT OF THALIDOMIDE ADMINISTRATION ON GABA AND OTHER AMINO-ACIDS IN THE MARMOSET EMBRYO | 0 | 0 |
2618 | 0 | 0 | 979 1988 TERATOLOGY 38(3):201-202 FRASER FC THALIDOMIDE RETROSPECTIVE - WHAT DID WE LEARN | 1 | 4 |
2619 | 2 | 8 | 980 1988 TERATOLOGY 38(3):203-215 LENZ W A SHORT HISTORY OF THALIDOMIDE EMBRYOPATHY | 38 | 69 |
2620 | 3 | 17 | 981 1988 TERATOLOGY 38(3):217-219 WARKANY J WHY I DOUBTED THAT THALIDOMIDE WAS THE CAUSE OF THE EPIDEMIC OF LIMB DEFECTS OF 1959 TO 1961 | 2 | 3 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2621 | 2 | 7 | 982 1988 TERATOLOGY 38(3):221-226 KELSEY FO THALIDOMIDE UPDATE - REGULATORY ASPECTS | 16 | 28 |
2622 | 31 | 61 | 983 1988 TERATOLOGY 38(3):229-239 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 40 | 63 |
2623 | 22 | 219 | 984 1988 TERATOLOGY 38(3):241-251 BRENT RL; HOLMES LB CLINICAL AND BASIC SCIENCE LESSONS FROM THE THALIDOMIDE TRAGEDY - WHAT HAVE WE LEARNED ABOUT THE CAUSES OF LIMB DEFECTS | 6 | 36 |
2624 | 1 | 2 | 1030 1990 TERATOLOGY 41(2):239-239 MCCREDIE J PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY - COMMENT | 1 | 1 |
2625 | 4 | 12 | 1031 1990 TERATOLOGY 41(2):241-242 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2626 | 7 | 19 | 1032 1990 TERATOLOGY 41(2):243-244 KOCH HP PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 2 | 4 |
2627 | 4 | 10 | 1033 1990 TERATOLOGY 41(2):245-246 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 1 | 3 |
2628 | 2 | 9 | 1074 1992 TERATOLOGY 46(5):411-413 LIPSON AH THALIDOMIDE RETROSPECTIVE - WHAT DID THE CLINICAL TERATOLOGIST LEARN | 0 | 3 |
2629 | 0 | 0 | 1075 1992 TERATOLOGY 46(5):417-418 LENZ W A PERSONAL PERSPECTIVE ON THE THALIDOMIDE TRAGEDY | 2 | 5 |
2630 | 9 | 51 | 1297 1996 TERATOLOGY 54(3):126-134 Smith DM; Torres RD; Stephens TD Mesonephros has a role in limb development and is related to thalidomide embryopathy | 0 | 5 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2631 | 8 | 17 | 1298 1996 TERATOLOGY 54(6):273-277 Castilla EE; AshtonProlla P; BarredaMejia E; Brunoni D; Cavalcanti DP; CorreaNeto J; Delgadillo JL; Dutra MG; Felix T; Giraldo A; Juarez N; LopezCamelo JS; Nazer J; Orioli IM; Paz JE; Pessoto MA; PinaNeto JM; Quadrelli R; Rittler M; Rueda S; Saltos M; Sanchez O; Schuler L Thalidomide, a current teratogen in South America | 14 | 17 |
2632 | 84 | 136 | 1604 1999 TERATOLOGY 60(5):306-321 Miller MT; Stromland K Teratogen update: Thalidomide: A review, with a focus on ocular findings and new potential uses | 5 | 16 |
2633 | 11 | 41 | 1793 2000 TERATOLOGY 61(3):189-195 Stephens TD; Fillmore BJ Hypothesis: Thalidomide embryopathy - Proposed mechanism of action | 17 | 30 |
2634 | 1 | 3 | 1794 2000 TERATOLOGY 62(3):172-173 Adams J; Buttar HS; Chambers C; Collins TFX; Graham JM; Jones KL; Kweder S; Mitala J; Polifka JE; Schwetz BA; Public Affairs Comm Teratology society public affairs committee position paper: Thalidomide | 0 | 1 |
2635 | 23 | 35 | 2289 2002 TERATOLOGY 66(3):115-121 Stromland K; Philipson E; Gronlund MA Offspring of male and female parents with thalidomide embryopathy: Birth defects and functional anomalies | 1 | 3 |
2636 | 4 | 18 | 1795 2000 TETRAHEDRON LETTERS 41(14):2275-2278 Luzzio FA; Mayorov AV; Figg WD Thalidomide metabolites. Part 1: Derivatives of (+)-2-(N-phthalimido)-gamma-hydroxyglutamic acid | 3 | 7 |
2637 | 8 | 25 | 1796 2000 TETRAHEDRON LETTERS 41(37):7151-7155 Luzzio FA; Thomas EM; Figg WD Thalidomide metabolites and analogs. Part 2: Cyclic derivatives of 2-N-phthalimido-2S,3S (3-hydroxy) ornithine | 4 | 6 |
2638 | 7 | 18 | 1222 1995 TETRAHEDRON-ASYMMETRY 6(6):1249-1252 ROBIN S; ZHU J; GALONS H; PHAMHUY C; CLAUDE JR; TOMAS A; VIOSSAT B A CONVENIENT ASYMMETRIC-SYNTHESIS OF THALIDOMIDE | 8 | 19 |
2639 | 27 | 34 | 2290 2002 THERAPEUTIC DRUG MONITORING 24(1):104-110 Price DK; Ando Y; Kruger EA; Weiss M; Figg WD 5 '-OH-thalidomide, a metabolite of thalidomide, inhibits angiogenesis | 9 | 10 |
2640 | 22 | 32 | 2291 2002 THERAPIE 57(6):524-529 Boulin M; Blanchet F; Isambert N; Solary E; Solier S; Collin B; Pernot C; Durnet-Archeray MJ Role of thalidomide with or without dexamethasone for refractory multiple myeloma | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2641 | 13 | 19 | 2683 2004 THROMBOSIS AND HAEMOSTASIS 91(4):834-836 Potenza L; Luppi M; Morselli M; Saviola A; Ferrari A; Riva G; Longo G; Marietta M; Torelli G Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making | 0 | 0 |
2642 | 32 | 52 | 2014 2001 TOXICOLOGICAL SCIENCES 59(1):160-168 Teo SK; Evans MG; Brockman MJ; Ehrhart J; Morgan JM; Stirling DI; Thomas SD Safety profile of thalidomide after 53 weeks of oral administration in beagle dogs | 4 | 4 |
2643 | 6 | 14 | 355 1965 TOXICOLOGY AND APPLIED PHARMACOLOGY 7(2):165-& DROBECK HP; COULSTON F; CORNELIU.D EFFECTS OF THALIDOMIDE ON FETAL DEVELOPMENT IN RABBITS AND ON ESTABLISHMENT OF PREGNANCY IN MONKEYS | 5 | 19 |
2644 | 13 | 41 | 356 1965 TOXICOLOGY AND APPLIED PHARMACOLOGY 7(2):268-& FRATTA ID; SIGG EB; MAIORANA K TERATOGENIC EFFECTS OF THALIDOMIDE IN RABBITS RATS HAMSTERS AND MICE | 15 | 34 |
2645 | 0 | 1 | 357 1965 TOXICOLOGY AND APPLIED PHARMACOLOGY 7(3):481-& DELAHUNT CS; KISS N; FELDMAN E; OAKES M SOME COMPARATIVE PHARMACOLOGICAL STUDIES IN MAN AND MONKEY WITH THALIDOMIDE | 3 | 6 |
2646 | 8 | 14 | 358 1965 TOXICOLOGY AND APPLIED PHARMACOLOGY 7(5):686-& HOMBURGE.F; CHAUBE S; EPPENBER.M; BOGDONOF.PD; NIXON CW SUSCEPTIBILITY OF CERTAIN INBRED STRAINS OF HAMSTERS TO TERATOGENIC EFFECTS OF THALIDOMIDE | 0 | 16 |
2647 | 11 | 17 | 536 1971 TOXICOLOGY AND APPLIED PHARMACOLOGY 18(1):208-& LEHMANN H; NIGGESCH.A TERATOLOGIC EFFECTS OF THALIDOMIDE IN HIMALAYAN RABBITS | 2 | 11 |
2648 | 0 | 0 | 537 1971 TOXICOLOGY AND APPLIED PHARMACOLOGY 19(2):372-& KELLER GR; BLAKE DA COMPARATIVE STUDIES ON ABSORPTION OF H-3 THALIDOMIDE IN RABBITS AND RATS | 0 | 0 |
2649 | 6 | 23 | 588 1973 TOXICOLOGY AND APPLIED PHARMACOLOGY 25(1):77-83 GILANI SH CARDIOVASCULAR MALFORMATIONS IN CHICK-EMBRYO INDUCED BY THALIDOMIDE | 1 | 4 |
2650 | 3 | 15 | 934 1986 TOXICOLOGY AND APPLIED PHARMACOLOGY 82(1):175-179 BRAUN AG; HARDING FA; WEINREB SL TERATOGEN METABOLISM - THALIDOMIDE ACTIVATION IS MEDIATED BY CYTOCHROME-P-450 | 27 | 34 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2651 | 19 | 37 | 1797 2000 TOXICOLOGY AND APPLIED PHARMACOLOGY 165(3):237-244 Karrow NA; McCay JA; Brown RD; Musgrove DL; Pettit DA; Munson AE; Germolec DR; White KL Thalidomide stimulates splenic IgM antibody response and cytotoxic T lymphocyte activity and alters leukocyte subpopulation numbers in female B6C3F1 mice | 5 | 8 |
2652 | 7 | 15 | 1001 1989 TOXICOLOGY LETTERS 45(1):23-33 SCHMAHL HJ; HEGER W; NAU H THE ENANTIOMERS OF THE TERATOGENIC THALIDOMIDE ANALOG EM-12 .2. CHEMICAL-STABILITY, STEREOSELECTIVITY OF METABOLISM AND RENAL EXCRETION IN THE MARMOSET MONKEY | 7 | 17 |
2653 | 0 | 16 | 1034 1990 TOXICOLOGY LETTERS 50(2-3):309-318 SHIOTA K; UWABE C; YAMAMOTO M; ARISHIMA K SUSCEPTIBILITY TO CYCLOPHOSPHAMIDE AND THALIDOMIDE OF FETAL-RAT LIMB BUDS GRAFTED IN ATHYMIC (NUDE) MICE | 0 | 0 |
2654 | 5 | 8 | 473 1968 TRANSPLANTATION 6(3):476-& MOUZAS GL; GERSHON RK EFFECT OF THALIDOMIDE ON SKIN ALLOGRAFTS IN MICE - SURVIVAL OF GRAFTS | 8 | 9 |
2655 | 8 | 20 | 935 1986 TRANSPLANTATION 41(5):644-647 VOGELSANG GB; HESS AD; GORDON G; SANTOS GW TREATMENT AND PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH THALIDOMIDE IN A RAT MODEL | 47 | 71 |
2656 | 11 | 26 | 1035 1990 TRANSPLANTATION 49(1):20-25 TAMURA F; VOGELSANG GB; REITZ BA; BAUMGARTNER WA; HERSKOWITZ A COMBINATION THALIDOMIDE AND CYCLOSPORINE FOR CARDIAC ALLOGRAFT-REJECTION - COMPARISON WITH COMBINATION METHYLPREDNISOLONE AND CYCLOSPORINE | 20 | 26 |
2657 | 13 | 17 | 1051 1991 TRANSPLANTATION 52(5):908-910 KEENAN RJ; EIRAS G; BURCKART GJ; STUART RS; HARDESTY RL; VOGELSANG G; GRIFFITH BP; ZEEVI A IMMUNOSUPPRESSIVE PROPERTIES OF THALIDOMIDE - INHIBITION OF INVITRO LYMPHOCYTE-PROLIFERATION ALONE AND IN COMBINATION WITH CYCLOSPORINE OR FK506 | 39 | 44 |
2658 | 1 | 7 | 936 1986 TRANSPLANTATION PROCEEDINGS 18(4):904-906 VOGELSANG GB; TAYLOR S; GORDON G; HESS AD THALIDOMIDE, A POTENT AGENT FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE | 19 | 27 |
2659 | 2 | 6 | 953 1987 TRANSPLANTATION PROCEEDINGS 19(1):2658-2661 VOGELSANG GB; HESS AD; GORDON G; BRUNDRETTE R; SANTOS GW THALIDOMIDE INDUCTION OF BONE-MARROW TRANSPLANTATION TOLERANCE | 24 | 32 |
2660 | 4 | 8 | 985 1988 TRANSPLANTATION PROCEEDINGS 20(2):226-228 VOGELSANG GB; WELLS MC; SANTOS GW; CHEN TL; HESS AD COMBINATION LOW-DOSE THALIDOMIDE AND CYCLOSPORINE PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN A RAT MISMATCHED MODEL | 14 | 16 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2661 | 4 | 6 | 1076 1992 TRANSPLANTATION PROCEEDINGS 24(6):2560-2561 ERIKSSON T; RIESBECK K; OSTRAAT O; EKBERG H; BJORKMAN S DRUG EXPOSURE AND FLOW-CYTOMETRY ANALYSES IN A THALIDOMIDE TREATMENT SCHEDULE THAT PROLONGS RAT CARDIAC GRAFT-SURVIVAL | 6 | 7 |
2662 | 5 | 7 | 1077 1992 TRANSPLANTATION PROCEEDINGS 24(6):2624-2625 OSTRAAT O; EKBERG H; SCHATZ H; RIESBECK K; ERIKSSON T THALIDOMIDE PROLONGS GRAFT-SURVIVAL IN RAT CARDIAC TRANSPLANTS | 9 | 9 |
2663 | 2 | 10 | 2684 2004 TRANSPLANTATION PROCEEDINGS 36(4):1018-1020 Chaves DNB; Petroianu A; Alberti LR; Pereira WA Effects of thalidomide, cyclosporine, and diclofenac on skin allograft survival in rabbits | 0 | 0 |
2664 | 0 | 1 | 715 1979 TRIAL 15(9):9-& PAGE JA SUFFER THE CHILDREN - THE STORY OF THALIDOMIDE - INSIGHT-TEAM-OF-THE-SUNDAY-TIMES-OF-LONDON | 0 | 0 |
2665 | 0 | 0 | 1078 1992 TROPICAL DOCTOR 22(3):139-139 AWOFESO N THALIDOMIDE PERIPHERAL NEUROPATHY | 1 | 4 |
2666 | 0 | 0 | 1079 1992 TROPICAL DOCTOR 22(3):139-140 WATERS MFR THALIDOMIDE PERIPHERAL NEUROPATHY - REPLY | 2 | 4 |
2667 | 6 | 28 | 1390 1997 TUBERCLE AND LUNG DISEASE 78(1):47-55 Moreira AL; Tsenova-Berkova L; Wang J; Laochumroonvorapong P; Freeman S; Freedman VH; Kaplan G Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis | 21 | 46 |
2668 | 14 | 32 | 2685 2004 UROLOGY 63(6):1061-1065 Clark PE; Hall MC; Miller A; Ridenhour KP; Stindt D; Lovato JF; Patton SE; Brinkley W; Das S; Torti FM Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma | 0 | 0 |
2669 | 4 | 5 | 410 1966 VETERINARY RECORD 78(25):883-& JAFFE WP FAILURE OF THALIDOMIDE TO INFLUENCE HOMOGRAFT IMMUNITY IN CHICKENS | 5 | 5 |
2670 | 7 | 25 | 2564 2003 WORLD JOURNAL OF SURGERY 27(10):1119-1123 Mall JW; Schwenk W; Philipp AW; Buttemeyer R; Pollmann C Intraperitoneal administration of the angiogenesis inhibitor thalidomide does not impair anastomotic healing following large bowel resection in a rabbit model | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2671 | 12 | 23 | 2565 2003 XENOTRANSPLANTATION 10(5):470-474 Yamamoto S; Cooper DKC An investigation of the effect of thalidomide on anti-gal antibody production in baboons | 0 | 0 |
2672 | 0 | 1 | 606 1974 ZEITSCHRIFT FUR ENTWICKLUNGSPSYCHOLOGIE UND PADAGOGISCHE PSYCHOLOGIE 6(1):63-65 MERKER H PRENATAL DAMAGE TO CHILDREN WITH RESPECT TO SCHOOL COMMUNITY - HAMBURG MODEL FOR EDUCATION OF THALIDOMIDE DAMAGED CHILDREN - GERMAN - KIRCHHOFF,H | 0 | 0 |
2673 | 0 | 0 | 538 1971 ZEITSCHRIFT FUR KREISLAUFFORSCHUNG 60(7):672-& KECK EW; ROLOFF D; MARKWORT.P CARDIOVASCULAR FINDINGS IN CHILDREN WITH THALIDOMIDE-DYSMELIA SYNDROME | 0 | 0 |
2674 | 13 | 145 | 662 1977 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 32(3-4):241-248 HANAUSKEABEL H; GUNZLER V INHIBITION OF HUMAN PROLYL HYDROXYLASE AS COMMON BIOCHEMICAL DENOMINATOR OF NON-SEDATIVE EFFECTS OF THALIDOMIDE IN MAN | 6 | 8 |
2675 | 3 | 8 | 770 1981 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 36(9-10):904-906 KOCHERBECKER U; KOCHER W; OCKENFELS H THALIDOMIDE-LIKE MALFORMATIONS CAUSED BY A TWEEN SURFACTANT IN MICE | 3 | 6 |
2676 | 5 | 17 | 937 1986 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 41(11-12):1057-1061 KOCH HP; CZEJKA MJ EVIDENCE FOR THE INTERCALATION OF THALIDOMIDE INTO DNA - CLUE TO THE MOLECULAR MECHANISM OF THALIDOMIDE TERATOGENICITY | 8 | 10 |
2677 | 6 | 37 | 1080 1992 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 47(1-2):155-169 KOCHERBECKER U; KOCHER W; OCKENFELS H EMBRYOTOXIC INTERACTIONS BETWEEN A HYDROLYSIS PRODUCT OF THALIDOMIDE AND THE SURFACTANT TWEEN 20 IN MICE | 0 | 0 |
2678 | 20 | 72 | 539 1971 ZEITSCHRIFT FUR NEUROLOGIE 200(3):219-& LIEBALDT GP; BROSER F WHAT IS RELEVANCE VARIOUS PREVIOUS DAMAGES OF PERIPHERAL NERVOUS SYSTEM TO A THALIDOMIDE POLYNEUROPATHY - CLINICO-NEUROPATHOLOGIC DIFFERENTIAL DIAGNOSIS OF DIFFERENT TYPES OF POLYNEURITIS AND POLYNEUROPATHY | 0 | 0 |
2679 | 0 | 2 | 589 1973 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 111(1):93-103 HUENGES E; IMMICH H; MARQUARD.E; ROMPE G; GRESSMAN.C; MAU H DOCUMENTATION AND REPORT ON THALIDOMIDE DAMAGE | 1 | 3 |
2680 | 1 | 12 | 607 1974 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 112(3):408-411 GRESSMAN.C GROWTH IN LENGTH OF CHILDREN DAMAGED THROUGH THALIDOMIDE | 0 | 3 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
2681 | 0 | 3 | 608 1974 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 112(4):1003-1005 RUFFING L CHANGES OF SHOULDER-JOINT IN DISTAL ECTROMELIA AS PART OF THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2682 | 0 | 0 | 688 1978 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 116(4):571-572 MATTHIASS HH; RUFFING L DEVELOPMENT OF SKELETAL AND MOTOR APPARATUS IN ADOLESCENTS WITH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
2683 | 1 | 9 | 739 1980 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 118(4):464-464 RUFFING L HIGH-INCIDENCE OF SPONDYLOLYSIS AND SPONDYLOLISTHESIS AMONG THALIDOMIDE BABIES AS PROOF FOR THE SO-CALLED DYSPLASTIC THEORY | 0 | 0 |
2684 | 0 | 0 | 838 1983 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 121(4):526-526 RUFFING L DISTURBANCES OF DISK DIFFERENTIATION DUE TO THALIDOMIDE | 0 | 0 |
2685 | 0 | 0 | 689 1978 ZEITSCHRIFT FUR RHEUMATOLOGIE 37:427-431 RUFFING L ANKYLOSIS OF SPINE IN THALIDOMIDE EMBRYOPATHIES | 0 | 0 |
Page 9: 1 2 3 4 5 6 7 8 9
Generated by:
HistCite(Vlad).
Version: 2004.09.22